Home › NDC Lookup › RxCUI directory › RxCUI 2046376

0.5 ML pegvaliase-pqpz 5 MG/ML Prefilled Syringe [Palynziq] — RxCUI 2046376

RxNorm drug concept · Semantic branded drug
RxCUI 2046376 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2046376
Official name0.5 ML pegvaliase-pqpz 5 MG/ML Prefilled Syringe [Palynziq]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as0.5 ML Palynziq 5 MG/ML Prefilled Syringe; Palynziq 2.5 MG in 0.5 mL Prefilled Syringe; Palynziq 2.5 MG per 0.5 ML Prefilled Syringe
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)767 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pegvaliase-pqpz Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Palynziq can cause a rare but life-threatening allergic reaction called anaphylaxis, so the FDA requires that it only be available through a tightly controlled safety program calle...
  • Why do I have to enroll in a special program just to get this medication?
  • Anaphylaxis can feel like your throat suddenly tightening, trouble breathing or wheezing, your heart racing, feeling faint or dizzy, or severe swelling of your face and lips. It us...
  • What does anaphylaxis actually look and feel like, and what should I do if it happens?
📖 Read our full Pegvaliase-pqpz Injection guide →

🕸️ Concept Web — How 0.5 ML pegvaliase-pqpz 5 MG/ML Prefilled Syringe... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.5 ML pegvaliase-pqpz 5 MG/ML Prefilled Syringe [Palynziq] RxCUI 2046376

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pegvaliase 2046360
    • Pegvaliase-pqpz 2046361
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Palynziq 2046366
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pegvaliase Prefilled Syringe 2046364
    • Pegvaliase-pqpz Prefilled Syringe 2649177
    • Pegvaliase Injectable Product 2046363
    • Pegvaliase-pqpz Injectable Product 2659352
    • Pegvaliase Prefilled Syringe [Palynziq] 2046368
    • Pegvaliase-pqpz Prefilled Syringe [Palynziq] 2655031
    • Palynziq Injectable Product 2046369
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 0.5 ML pegvaliase-pqpz 5 MG/ML Prefilled Syringe SCD · 2046374
  • Pegvaliase-pqpz 5 MG/ML SCDC · 2046373
  • Pegvaliase Prefilled Syringe SCDF · 2046364
  • Pegvaliase-pqpz Prefilled Syringe SCDFP · 2649177
  • Pegvaliase Injectable Product SCDG · 2046363
  • Pegvaliase-pqpz Injectable Product SCDGP · 2659352

Brand-Name Concepts

  • Pegvaliase-pqpz 5 MG/ML [Palynziq] SBDC · 2046375
  • Pegvaliase Prefilled Syringe [Palynziq] SBDF · 2046368
  • Pegvaliase-pqpz Prefilled Syringe [Palynziq] SBDFP · 2655031
  • Palynziq Injectable Product SBDG · 2046369
  • Palynziq BN · 2046366

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 2046376 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68135-0058-90 1 SYRINGE in 1 CARTON (68135-058-90) / .5 mL in 1 SYRINGE (... Palynziq BioMarin Pharmaceutical Inc. 2018-05-24
68135-0673-40 1 SYRINGE in 1 CARTON (68135-673-40) / 1 mL in 1 SYRINGE (6... Palynziq BioMarin Pharmaceutical Inc. 2018-05-24
68135-0673-45 10 SYRINGE in 1 CARTON (68135-673-45) / 1 mL in 1 SYRINGE (... Palynziq BioMarin Pharmaceutical Inc. 2018-05-24
68135-0756-20 1 SYRINGE in 1 CARTON (68135-756-20) / .5 mL in 1 SYRINGE (... Palynziq BioMarin Pharmaceutical Inc. 2018-05-24
Observed labelers: BioMarin Pharmaceutical Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.